Measurable Solutions For Health Equity
The goal of the Beacon of Hope initiative is to co-create effective, measurable solutions for health equity, focusing in three key areas:
Disparities are endemic across our healthcare system. Novartis and the Novartis US Foundation have taken a major step forward to address the root causes of disparities in health and education by launching Beacon of Hope, an innovative ten-year collaboration with 26 Historically Black Colleges and Universities (HBCUs), including four HBCU Medical Schools, Merck, Sanofi, the National Medical Association, Thurgood Marshall College Fund, and Coursera.
Enabling the Next Generation of Leaders
The Beacon of Hope collaboration has made significant progress in empowering the next generation of African American, Black and Hispanic students to become healthcare leaders.
Clinical Trials Centers of Excellence
The program establishes clinical trial Centers of Excellence at the four Historically Black Medical Schools to increase diversity among clinical trial investigators and participants.
Research Centers of Excellence
In addition to promoting diversity in clinical trials, Beacon of Hope is supporting the creation of two additional Centers of Excellence at Morehouse School of Medicine.
Addressing Health Inequities Starts By Looking Within
Read about the significance of Beacon of Hope from Patrice Matchaba, M.D., Head, US Corporate Responsibility and President, Novartis US Foundation in this interview.
Beacon of Hope Pledge
Stakeholders who signed the original Beacon of Hope Pledge committed to collaboration in finding solutions to addressing systemic disparities in education and health outcomes to create greater diversity, equity and inclusion across the research and development ecosystem.